Zirconium (89Zr) Crefmirlimab Berdoxam

6 trials 4 recruiting

Filter these 6 trials by condition, phase, country and more.

Open in Search →

6 Registered trials

4 Recruiting

1 Completed trials

5 Sponsors

3 Countries

Phase II/III

Phase II

Phase I/II

Phase I (Other)

Phase II/III: 1 Phase II: 2 Phase I/II: 2 Phase I (Other): 1

Indications tested

Malignant melanoma 1

Sponsors using this IMP

Universitair Medisch Centrum Groningen 2 Amsterdam UMC 1 Leids Universitair Medisch Centrum (LUMC) 1 Radboud universitair medisch centrum Stichting 1 Universitaetsklinikum Tuebingen AöR 1

All trials

6 total

T cell imaging in kidney transplantation (TIK) Pending

2025-522490-11-00 Phase I (Other) 1 country Radboud universitair medisch centrum Stichting
CD8 PET imaging in metastatic solid tumours; A phase II, open label, multi-center study of 89Zr-DF-crefmirlimab for CD8 positron emission to… Recruiting

2024-515885-15-00 Phase I/II 2 countries Universitair Medisch Centrum Groningen
ACTME Recruiting

2024-516125-31-02 Phase I/II 1 country Leids Universitair Medisch Centrum (LUMC)
Imaging of inflamed arteries in giant cell arteritis and inflamed joints in rheumatoid arthritis with a PET/CT scan. Recruiting

2024-514489-38-01 Phase II 1 country Universitair Medisch Centrum Groningen
Early detection of side effects in patients with metastatic melanoma receiving immune checkpoint inhibitor therapy by investigation of the C… Recruiting

2024-512219-37-00 Phase II 1 country Universitaetsklinikum Tuebingen AöR
Evaluating T Cell Changes and Activation in Cancer Patient Using Two PET Tracers (iRelate) Ended

2023-509486-20-00 Phase II/III 1 country Amsterdam UMC

Showing 1–6 of 6 trials

← All drugs A–Z